BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/24/2025 5:39:17 AM | Browse: 391 | Download: 931
Publication Name World Journal of Stem Cells
Manuscript ID 99331
Country Portugal
ISSN 1948-0210 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, Research & Experimental
Manuscript Type Minireviews
Article Title Induced pluripotent stem cells-derived mesenchymal stem cells for modelling and treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Challenges and opportunities
Manuscript Source Invited Manuscript
All Author List Bárbara Silva and José Bragança
ORCID
Author(s) ORCID Number
Bárbara Silva http://orcid.org/0000-0002-3314-7936
José Bragança http://orcid.org/0000-0001-9566-400X
Funding Agency and Grant Number
Funding Agency Grant Number
American Heart Association Award 24IVPHA1288417
FCT Fellowships 2022.13253.BDANA
Corresponding Author José Bragança, Associate Professor, PhD, Faculty of Medicine and Biomedical Sciences, Algarve Biomedical Center-Research Institute, University of Algarve, Campus of Gambelas, Building 8, Room 2.22, Faro 8005-139, Portugal. jebraganca@ualg.pt
Key Words Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Mesenchymal stem cells; Induced pluripotent stem cells; In vitro liver models
Core Tip Induced pluripotent stem cells (iPSCs) show promise for modelling and treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. iPSCs can generate various cell types, including cells for therapy or disease modelling. Challenges remain, but iPSCs offer potential for drug discovery and personalized medicine approaches for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.
Publish Date 2025-02-24 05:39
Citation

Silva B, Bragança J. Induced pluripotent stem cells-derived mesenchymal stem cells for modelling and treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Challenges and opportunities. World J Stem Cells 2025; 17(2): 99331

URL https://www.wjgnet.com/1948-0210/full/v17/i2/99331.htm
DOI https://dx.doi.org/10.4252/wjsc.v17.i2.99331
Full Article (PDF) WJSC-17-99331-with-cover.pdf